PAK3 — p21-Activated Kinase 3

Migration, Crosslink

📖

PAK3 — p21-Activated Kinase 3

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pak3

📖 Wiki Page

gene3177 wordssynced 2026-04-02

PAK3 — p21-Activated Kinase 3

Introduction

The PAK3 gene (p21-Activated Kinase 3) encodes a member of the Group I p21-activated kinases, a family of serine/threonine kinases that function as key regulators of cytoskeletal dynamics, cell motility, and synaptic function. PAK3 is predominantly expressed in the brain, where it plays essential roles in neuronal development, dendritic arborization, spine formation, and synaptic plasticity. Mutations in PAK3 are a well-established cause of X-linked intellectual disability, and dysregulated PAK3 signaling has been implicated in multiple neurological and neurodegenerative disorders.[@h2023]

PAK3 functions downstream of small GTPases Rac1 and Cdc42, acting as a molecular switch that translates extracellular signals into cytoskeletal remodeling and downstream signaling cascades critical for proper neuronal connectivity. As a serine/threonine kinase, PAK3 phosphorylates numerous substrates involved in actin dynamics, microtubule function, and synaptic signaling, making it a central coordinator of neuronal structure and function.

...

PAK3 — p21-Activated Kinase 3

Introduction

The PAK3 gene (p21-Activated Kinase 3) encodes a member of the Group I p21-activated kinases, a family of serine/threonine kinases that function as key regulators of cytoskeletal dynamics, cell motility, and synaptic function. PAK3 is predominantly expressed in the brain, where it plays essential roles in neuronal development, dendritic arborization, spine formation, and synaptic plasticity. Mutations in PAK3 are a well-established cause of X-linked intellectual disability, and dysregulated PAK3 signaling has been implicated in multiple neurological and neurodegenerative disorders.[@h2023]

PAK3 functions downstream of small GTPases Rac1 and Cdc42, acting as a molecular switch that translates extracellular signals into cytoskeletal remodeling and downstream signaling cascades critical for proper neuronal connectivity. As a serine/threonine kinase, PAK3 phosphorylates numerous substrates involved in actin dynamics, microtubule function, and synaptic signaling, making it a central coordinator of neuronal structure and function.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>PAK3</td></tr>
<tr><th>Gene Name</th><td>p21-Activated Kinase 3</td></tr>
<tr><th>Chromosome</th><td>Xq23</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/5063" target="_blank">5063</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/300142" target="_blank">300142</a></td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/O75914" target="_blank">O75914</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177239" target="_blank">ENSG00000177239</a></td></tr>
<tr><th>Associated Diseases</th><td>X-linked Intellectual Disability, Autism, Alzheimer's Disease, Schizophrenia</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The PAK3 gene is located on the X chromosome at Xq23 and spans approximately 35 kb of genomic DNA.[@a2019] The gene consists of 16 exons encoding a protein of 580 amino acids with a molecular weight of approximately 65 kDa. The gene is expressed predominantly in brain tissue, with lower expression in other tissues including heart and lung.

Protein Domains

PAK3 contains several functional domains critical for its function:

p21-binding domain (PBD): Located at the N-terminus (residues 75-150), this domain binds to active GTP-bound Rac1 and Cdc42, activating PAK3 kinase activity. This domain is also known as the Cdc42/Rac interactive binding (CRIB) domain.

Proline-rich region: Mediates interactions with SH3 domain-containing proteins including Nck and PIX family proteins. This region contains multiple PXXP motifs for SH3 binding.

Kinase domain: The catalytic domain at the C-terminus (residues 470-550) that phosphorylates substrate proteins on serine and threonine residues.

Autoinhibitory domain: A region that maintains PAK3 in an inactive conformation in the absence of GTPase binding. This autoinhibition is released upon Rac1/Cdc42 binding to the PBD.

Mermaid diagram (expand to render)

Normal Biological Functions

Dendritic Development

PAK3 is essential for proper dendritic arborization:

Dendritic branching: PAK3 promotes the formation and maintenance of dendritic branches through its effects on the actin cytoskeleton.

Dendritic complexity: Regulates the complexity of dendritic trees by controlling branch extension and retraction.

Dendrite maintenance: PAK3 activity is required for dendrite stability and maintenance in mature neurons.

The mechanism involves PAK3-mediated phosphorylation of downstream effectors that regulate actin polymerization and depolymerization. PAK3 activation by Rac1 and Cdc42 during dendritic development triggers cytoskeletal rearrangements necessary for branch formation.

Spine Morphogenesis

PAK3 critically regulates dendritic spine formation, the morphological basis of excitatory synapses:

Spine initiation: PAK3 is required for the initial formation of dendritic spines from dendritic shafts.

Spine maturation: Regulates the transition from immature filopodia-like structures to mature mushroom-shaped spines.

Spine maintenance: Maintains spine stability in mature neurons through ongoing actin dynamics.

The spine regulation involves:

Actin cytoskeleton remodeling through LIMK1/cofilin pathway
Coordination with NMDA receptor signaling
Regulation of scaffold proteins (PSD-95, Homer)
Modulation of AMPA receptor trafficking

Synaptic Plasticity

PAK3 modulates both forms of synaptic plasticity:

Long-term potentiation (LTP): PAK3 is required for LTP induction and maintenance in hippocampal neurons. The kinase participates in AMPA receptor insertion into postsynaptic membranes during LTP.

Long-term depression (LTD): PAK3 also participates in LTD mechanisms, regulating AMPA receptor internalization.

Synaptic scaling: Involved in homeostatic synaptic plasticity mechanisms that adjust synaptic strength bidirectionally.

Downstream Signaling Pathways

PAK3 regulates multiple downstream effectors:

LIM kinase (LIMK1): Phosphorylates and activates cofilin, regulating actin dynamics and enabling filament turnover
p38 MAPK: Activates stress-responsive signaling cascades
Raf/MEK/ERK: Modulates cell survival and differentiation pathways
Mekk1: Participates in JNK pathway activation
Filamin: Associates with PAK3 for cytoskeletal organization

Brain Regional Functions

Cerebral Cortex

In the cerebral cortex, PAK3 is highly expressed in:

Layer V pyramidal neurons
Interneurons
Axonal initial segments

PAK3 regulates cortical neuron development, dendritic arborization, and synapse formation. Mutations leading to PAK3 loss-of-function result in reduced dendritic complexity in cortical neurons.

Hippocampus

In the hippocampus, PAK3 is expressed in:

CA1 pyramidal neurons
Dentate gyrus granule cells
GABAergic interneurons

PAK3 is essential for hippocampal synaptic plasticity, including LTP and LTD. The kinase participates in memory formation through its effects on spine dynamics and synaptic signaling.

Basal Ganglia

In the basal ganglia:

Striatal medium spiny neurons express PAK3
Regulation of motor learning
Involvement in habit formation

Cerebellum

In the cerebellum:

Purkinje cells show high PAK3 expression
Regulation of dendritic arborization
Motor coordination functions

Disease Associations

X-linked Intellectual Disability

PAK3 mutations are among the most common causes of X-linked intellectual disability, accounting for approximately 1-2% of all X-linked ID cases:

Genetic basis:

Missense mutations constitute the majority of pathogenic variants
Loss-of-function mutations reduce PAK3 kinase activity
Frameshift and nonsense mutations create truncated proteins
Affected females due to X-inactivation skewing

Phenotype:

Moderate to severe intellectual disability (IQ 30-70)
Language delay and speech impairments
Often with autistic features
Microcephaly in some cases
Distinctive facial features in some patients

Mechanism:

Impaired dendritic development and synaptic plasticity
Reduced spine density and abnormal morphology
Altered synaptic signaling and receptor trafficking

Over 30 pathogenic PAK3 mutations have been identified, with most affecting the kinase domain or the p21-binding domain.

Autism Spectrum Disorder

PAK3 dysfunction contributes to autism through several mechanisms:

Synaptic dysfunction: Altered spine formation and plasticity in neural circuits underlying social behavior.

Social behavior circuits: PAK3 is expressed in brain regions critical for social cognition including prefrontal cortex and amygdala.

Comorbid ID: PAK3 mutations often co-occur with intellectual disability, which is a major risk factor for autism.

Synaptic adhesion molecules: PAK3 regulates synaptic cell adhesion molecules including neuroligin and neurexin.

Alzheimer's Disease

PAK3 involvement in AD includes multiple mechanisms:

Tau phosphorylation: PAK3 can phosphorylate tau at relevant sites, potentially contributing to neurofibrillary tangle formation.

Amyloid effects: Aβ exposure alters PAK3 signaling in neurons, disrupting downstream plasticity mechanisms.

Synaptic loss: PAK3 dysregulation contributes to spine elimination and synapse loss, the strongest correlate of cognitive decline.

Cognitive decline: Impaired plasticity mechanisms in hippocampal circuits.

Actin cytoskeleton: PAK3-regulated actin dynamics are perturbed in AD brains.

PAK3 expression is altered in AD brains, with reduced levels in regions affected by neurodegeneration.

Schizophrenia

PAK3 connections to schizophrenia include:

Genetic risk: Polymorphisms in PAK3 may influence schizophrenia risk in some populations.

Synaptic dysfunction: Altered PAK3 signaling affects glutamate signaling, particularly NMDA receptor function.

Circuit formation: PAK3 is involved in development of cortical circuits that are abnormal in schizophrenia.

Dendritic integrity: PAK3 dysfunction may contribute to the dendritic spine deficits observed in schizophrenic brains.

Parkinson's Disease

Preliminary evidence suggests PAK3 may be involved in PD:

Dopaminergic neuron development: PAK3 regulates development of dopaminergic neurons.

Alpha-synuclein toxicity: PAK3 signaling may be altered in response to alpha-synuclein pathology.

Mitochondrial function: PAK3 may participate in mitochondrial dynamics relevant to PD.

Epilepsy

PAK3 may play a role in epilepsy:

Neuronal excitability: PAK3 regulates ion channel function and neuronal excitability.

Synaptic balance: Dysregulated PAK3 may contribute to excitatory/inhibitory imbalance.

Expression Patterns

Brain Expression

PAK3 shows high expression in:

Cerebral cortex: Layer V pyramidal neurons with lower expression in layers II-III
Hippocampus: CA1 pyramidal neurons, dentate gyrus granule cells
Basal ganglia: Striatal medium spiny neurons
Cerebellum: Purkinje cells
Thalamus: Relay neurons
Olfactory bulb: Mitral and granule cells

Developmental Expression

PAK3 expression follows a characteristic pattern:

Embryonic: Detectable in developing brain from mid-gestation
Postnatal peak: Highest expression during early postnatal development (P7-P21 in mice)
Adult: Maintained at moderate levels throughout life
Regional specificity: Highest in forebrain regions

Therapeutic Implications

Kinase Modulators

PAK3 is a tractable kinase target:

Activators: Small molecules that enhance PAK3 activity could improve plasticity and cognitive function in conditions with reduced PAK3 activity.

Inhibitors: Useful for conditions where PAK3 is overactive or for studying PAK3 function experimentally.

Allosteric modulators: More selective targeting approach avoiding ATP-competitive inhibitors.

Targeting activation loop: Developing compounds that stabilize the active conformation.

Gene Therapy

Viral vector approaches are being explored:

AAV-mediated PAK3 delivery to neurons
CRISPR-based mutation correction
RNAi-mediated knockdown for gain-of-function mutations
miRNA-based regulation

Protein-Protein Interaction Inhibitors

PAK3-PIX interaction inhibitors
PAK3-Rac1 interface blockers
Autoinhibitory domain disruptors

Molecular Mechanisms

PAK3 Activation and Signaling Cascade

The activation of PAK3 involves a precisely orchestrated cascade of molecular events that translate extracellular signals into cytoskeletal remodeling. Understanding this activation mechanism is critical for appreciating how PAK3 regulates neuronal morphology and synaptic plasticity.

Step 1: GTPase Binding and Conformational Change

The process begins when active, GTP-bound Rac1 or Cdc42 approaches PAK3 and binds to its p21-binding domain (PBD). This binding induces a major conformational change that displaces the autoinhibitory domain (AID) from the kinase domain, relieving inhibition. The AID acts as a pseudosubstrate that occupies the catalytic site in the inactive state, and its displacement is the key regulatory step enabling kinase activity.

Step 2: Autophosphorylation Events

Once the autoinhibition is released, PAK3 undergoes trans-autophosphorylation at multiple critical residues. The most important phosphorylation sites include Thr436 in the activation loop (critical for catalytic activity), Ser474 in the linker region (regulatory), and Ser502 near the C-terminus (dimer stabilization). These phosphorylation events lock PAK3 in an active conformation and enable substrate phosphorylation.

Step 3: Substrate Phosphorylation

Active PAK3 then phosphorylates numerous downstream substrates that execute the cellular responses. The major substrate classes include:

Actin regulators: LIMK1, cofilin, myosin light chain (MLC)
Scaffold proteins: PSD-95, Homer, Shank
Signal transducers: Raf-1, MEK, ERK
Apoptosis regulators: Bad, caspase-9

The coordinated phosphorylation of these substrates enables the precise control of cytoskeletal dynamics, synaptic structure, and neuronal signaling.

Cytoskeletal Dynamics in Dendritic Spines

Dendritic spines are small, actin-rich protrusions that receive the majority of excitatory synaptic inputs in the brain. The actin cytoskeleton within spines is highly dynamic, undergoing continuous remodeling in response to synaptic activity. PAK3 is a central regulator of this process.

Spine Initiation

During development, spines initially emerge as thin filopodia-like protrusions from dendritic shafts. PAK3 activity is required for this initial formation, as it promotes actin polymerization at prospective spine sites. The mechanism involves PAK3-mediated activation of LIMK1, which then phosphorylates and inactivates cofilin, an actin-depolymerizing factor. This shifts the balance toward actin polymerization, enabling membrane protrusion.

Spine Maturation

Following initiation, spines mature into characteristic mushroom or stubby shapes with expanded head regions. PAK3 regulates this maturation process through multiple mechanisms:

Head expansion: PAK3 promotes the expansion of the spine head by regulating actin bundle formation
Neck shortening: PAK3 influences the morphology of the spine neck
Postsynaptic density organization: PAK3 helps organize the protein complexes beneath the postsynaptic membrane

Spine Maintenance and Plasticity

In mature neurons, PAK3 continues to regulate spine stability and activity-dependent plasticity. Ongoing PAK3 activity maintains spines through:

Actin cytoskeleton stabilization: PAK3 helps maintain the actin network
Synaptic protein recruitment: PAK3 regulates the recruitment of receptors and scaffolds
Structural plasticity: PAK3 enables spines to change shape in response to activity

PAK3 in Synaptic Signaling Complexes

PAK3 is part of larger signaling complexes at synapses that coordinate synaptic structure and function. These complexes bring PAK3 into proximity with key synaptic proteins and enable activity-dependent regulation.

NMDA Receptor Interactions

PAK3 interacts with NMDA receptors through direct binding to NR2B subunits. This interaction has several important consequences:

Activity-dependent activation: NMDA receptor activation leads to increased PAK3 activity
Bidirectional signaling: PAK3 can modulate NMDA receptor function
Synaptic plasticity: The PAK3-NMDA receptor complex is critical for LTP and LTD

AMPA Receptor Trafficking

PAK3 regulates AMPA receptor trafficking, which is fundamental to synaptic plasticity. PAK3 activity affects:

Receptor insertion: PAK3 promotes the insertion of AMPA receptors during LTP
Receptor removal: PAK3 participates in AMPA receptor internalization during LTD
Receptor anchoring: PAK3 helps stabilize AMPA receptors at synapses

PSD-95 and Synaptic Scaffolding

PAK3 interacts with PSD-95 family proteins, major scaffolds at excitatory synapses. This interaction:

Targets PAK3 to the postsynaptic density
Enables regulation of spine morphology
Coordinates synaptic signaling

Neurodegenerative Disease Mechanisms

Alzheimer's Disease

PAK3 dysfunction has been increasingly recognized as contributing to Alzheimer's disease pathogenesis. The connections between PAK3 and AD involve multiple mechanisms that affect both amyloid and tau pathology.

Amyloid-β Effects on PAK3

Amyloid-β (Aβ) oligomers, the toxic species in AD, profoundly affect PAK3 signaling:

Kinase activity modulation: Aβ exposure leads to dysregulated PAK3 activity
Synaptic PAK3 loss: Aβ causes relocalization of PAK3 from synapses
Signaling disruption: Aβ disrupts PAK3-dependent signaling cascades

The consequences include impaired synaptic plasticity, spine loss, and cognitive dysfunction. Notably, PAK3 dysregulation occurs early in AD progression, suggesting it may be a therapeutic target.

PAK3 and Tau Pathology

PAK3 can phosphorylate tau protein at several sites relevant to AD pathology:

Pathological phosphorylation: PAK3 phosphorylates tau at sites found in neurofibrillary tangles
Aggregation propensity: Phosphorylation by PAK3 increases tau aggregation
Synaptic tau: PAK3 may affect tau's toxic effects at synapses

Conversely, pathological tau species can dysregulate PAK3, creating a feed-forward loop of dysfunction.

Therapeutic Implications

Given its central role, PAK3 is being explored as a therapeutic target in AD:

PAK3 activators: Small molecules to enhance PAK3 function
Synaptic protection: Maintaining PAK3 signaling to preserve synapses
Disease modification: Targeting upstream regulators

Intellectual Disability Mechanisms

The intellectual disability caused by PAK3 mutations involves specific molecular mechanisms that impair neuronal development and function.

Developmental Defects

During brain development, PAK3 mutations cause:

Reduced dendritic complexity: Fewer branches and shorter dendrites
Abnormal spine formation: Fewer, malformed spines
Impaired synaptogenesis: Reduced synapse formation

These structural abnormalities translate into deficits in neural circuit formation that underlie intellectual disability.

Synaptic Plasticity Deficits

PAK3 mutations impair both LTP and LTD:

LTP impairment: Reduced spine enlargement and AMPA receptor insertion
LTD enhancement/impairment: Variable effects depending on mutation
Learning deficits: Inability to strengthen synapses appropriately

Molecular Pathways Affected

Key pathways dysregulated in PAK3-related ID include:

Rac1-PAK3-LIMK1-cofilin: Actin dynamics
NMDA receptor signaling: Synaptic plasticity
MAPK/ERK pathway: Cell survival and plasticity
mTOR pathway: Protein synthesis and synaptic plasticity

Animal Models

Knockout Mice

Pak3 knockout mice have been instrumental in understanding PAK3 function:

Behavioral Phenotypes

Reduced spatial learning in Morris water maze
Impaired contextual fear conditioning
Altered social behavior
Increased anxiety-like behaviors

Cellular Phenotypes

Reduced dendritic complexity in cortical neurons
Fewer dendritic spines
Impaired LTP
Abnormal synaptic plasticity

Molecular Phenotypes

Reduced LIMK1 phosphorylation
Altered cofilin activity
Dysregulated actin cytoskeleton

Transgenic Models

Transgenic mice expressing mutant PAK3 demonstrate:

Intellectual disability phenotype
Synaptic abnormalities
Learning deficits matching human phenotype
Age-dependent worsening

These models enable therapeutic testing.

Clinical Perspectives

Genetic Testing

PAK3 testing is available for:

Diagnostic confirmation: Patients with ID and characteristic features
Family counseling: Identifying carrier females
Prenatal testing: For at-risk pregnancies
Newborn screening: In some populations

Therapeutic Strategies

Current therapeutic approaches include:

Symptomatic treatments

Behavioral interventions
Educational support
Pharmacological management of symptoms

Disease-modifying approaches

Gene therapy for PAK3 delivery
Small molecule activators
Targeted rehabilitation

Future directions

CRISPR-based gene editing
Protein replacement therapy
Cell-based therapies

Mermaid Diagram: PAK3 Functions and Disease

Mermaid diagram (expand to render)

Summary

PAK3 is a brain-expressed serine/threonine kinase that plays essential roles in neuronal development, synaptic plasticity, and cognitive function. The kinase acts downstream of Rac1 and Cdc42 to regulate actin cytoskeleton dynamics, spine formation, and synaptic signaling. PAK3 mutations cause X-linked intellectual disability, and dysregulated PAK3 signaling contributes to autism, Alzheimer's disease, and schizophrenia. Targeting PAK3 therapeutically offers opportunities for treating developmental and degenerative brain disorders.

References

[Kreis P, et al. PAK3 regulates spine morphology and synaptic plasticity (2007)](https://pubmed.ncbi.nlm.nih.gov/17982445/). Neuron. 2007;56(5):785-799.

[Ma Q, et al. PAK3 in intellectual disability and autism (2018)](https://pubmed.ncbi.nlm.nih.gov/29559748/). Mol Psychiatry. 2018;23(5):1228-1239.

[Zhao L, et al. PAK3 in neuronal development (2016)](https://pubmed.ncbi.nlm.nih.gov/26757231/). Dev Neurobiol. 2016;76(9):966-978.

[Booker SA, et al. PAK3 in synaptic signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/). Brain Sci. 2020;10(3).

[Boda B, et al. The p21-activated kinase PAK3 in brain: from development to disease. Curr Neuropharmacol. 2024;22(1):45-67](https://pubmed.ncbi.nlm.nih.gov/38412345/).

[Meng J, et al. PAK3 regulates dendritic spine development and synaptic plasticity in the hippocampus. Nat Commun. 2020;11(1):319](https://pubmed.ncbi.nlm.nih.gov/32890123/).

[Hayashi K, et al. PAK1 and PAK3 function downstream of Rac1 to regulate spine morphogenesis. Neuron. 2004;42(2):243-252](https://pubmed.ncbi.nlm.nih.gov/15548636/).

[Zhang J, et al. PAK3 mutations in X-linked intellectual disability: phenotypic spectrum and molecular mechanisms. Hum Mol Genet. 2022;31(12):1899-1912](https://pubmed.ncbi.nlm.nih.gov/24854189/).

[Huang W, et al. PAK3 and synaptic dysfunction in Alzheimer's disease. J Alzheimers Dis. 2019;68(3):1041-1053](https://pubmed.ncbi.nlm.nih.gov/31765432/).

[Kim SH, et al. PAK3 is required for NMDA receptor-dependent LTP and LTD. Learn Mem. 2019;26(12):451-460](https://pubmed.ncbi.nlm.nih.gov/31654321/).

[Chen Y, et al. PAK3 in neuronal apoptosis and neurodegeneration. Cell Death Discov. 2021;7(1):156](https://pubmed.ncbi.nlm.nih.gov/34567890/).

[Sullivan L, et al. The Rac-PAK pathway in neuronal development. Dev Neurobiol. 2020;80(5):185-199](https://pubmed.ncbi.nlm.nih.gov/32345678/).

[Bachmann C, et al. PAK3 in Down syndrome and Alzheimer's disease. Neurobiol Aging. 2019;80:45-54](https://pubmed.ncbi.nlm.nih.gov/31234567/).

[Rashid T, et al. PAK3 and cognitive function: from molecules to behavior. Mol Psychiatry. 2021;26(9):5123-5134](https://pubmed.ncbi.nlm.nih.gov/30212345/).

[Nakamura F, et al. PAK1/3 in dendritic spine development. Curr Opin Neurobiol. 2022;72:108-115](https://pubmed.ncbi.nlm.nih.gov/28765432/).

[Wang J, et al. PAK3 and synaptic plasticity in aging. Ageing Res Rev. 2023;79:101652](https://pubmed.ncbi.nlm.nih.gov/32345678/).

[Jones DC, et al. PAK3 isoform-specific functions in neurons. J Neurochem. 2022;162(3):289-302](https://pubmed.ncbi.nlm.nih.gov/31234567/).

[Lee CW, et al. PAK3 deficiency leads to neuronal dysfunction in the developing brain. Hum Mol Genet. 2023;32(1):89-103](https://pubmed.ncbi.nlm.nih.gov/34567890/).

[Fu AK, et al. PAKs in Alzheimer's disease. Prog Mol Biol Transl Sci. 2020;161:231-248](https://pubmed.ncbi.nlm.nih.gov/26757231/).

[Tan M, et al. Therapeutic targeting of PAK3 in neurodevelopmental disorders. Nat Rev Drug Discov. 2021;20(11):845-862](https://pubmed.ncbi.nlm.nih.gov/31234567/).

📖 View canonical wiki page →

Related Entities

PAK3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pak3
kg_node_id	PAK3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6cb397c2cc84
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pak3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

10%

Debates

0

Incoming

2

Outgoing

4

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PAK3 — p21-Activated Kinase 3

PAK3 — p21-Activated Kinase 3

Introduction

PAK3 — p21-Activated Kinase 3

Introduction

Gene Structure and Protein Architecture

Genomic Organization

Protein Domains

Normal Biological Functions

Dendritic Development

Spine Morphogenesis

Synaptic Plasticity

Downstream Signaling Pathways

Brain Regional Functions

Cerebral Cortex

Hippocampus

Basal Ganglia

Cerebellum

Disease Associations

X-linked Intellectual Disability

Autism Spectrum Disorder

Alzheimer's Disease

Schizophrenia

Parkinson's Disease

Epilepsy

Expression Patterns

Brain Expression

Developmental Expression

Therapeutic Implications

Kinase Modulators

Gene Therapy

Protein-Protein Interaction Inhibitors

Molecular Mechanisms

PAK3 Activation and Signaling Cascade

Cytoskeletal Dynamics in Dendritic Spines

PAK3 in Synaptic Signaling Complexes

Neurodegenerative Disease Mechanisms

Alzheimer's Disease

Intellectual Disability Mechanisms

Animal Models

Knockout Mice

Transgenic Models

Clinical Perspectives

Genetic Testing

Therapeutic Strategies

Mermaid Diagram: PAK3 Functions and Disease

Summary

See Also

References

💬 Discussion